Sonoma Pharmaceuticals In...
2.65
0.01 (0.38%)
At close: Jan 15, 2025, 9:31 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Revenue 12.73M 13.27M 12.63M 18.63M 18.94M 18.97M 16.66M 12.82M 15.08M 13.85M 13.67M 15.45M 12.74M 9.75M 7.36M 5.39M 3.83M 4.54M 2.58M 1.36M 902.00K 2.47M 2.00M
Cost of Revenue 7.99M 8.79M 8.63M 12.07M 10.60M 10.09M 9.35M 7.16M 7.87M 6.57M 5.27M 4.71M 4.03M 3.61M 3.49M 2.59M 2.75M 3.00M 4.90M 3.52M n/a 1.77M 815.00K
Gross Profit 4.75M 4.48M 3.99M 6.56M 8.33M 8.88M 7.31M 5.67M 7.21M 7.29M 8.40M 10.74M 8.71M 6.14M 3.88M 2.80M 1.08M 1.54M -2.32M -2.17M 902.00K 702.00K 1.19M
Operating Income -4.70M -4.57M -5.89M -3.45M -6.67M -11.26M -14.19M -12.97M -10.15M -6.66M -6.05M -3.37M -6.47M -7.50M -8.02M -17.31M -22.43M -19.48M -20.85M -16.31M 902.00K -1.47M -147.00K
Interest Income n/a 16.00K 10.00K 16.00K 50.00K 190.00K 258.00K 22.00K 2.00K 1K 1K 7.00K 4.00K 3.00K 2.00K 152.00K n/a n/a n/a n/a n/a n/a n/a
Pretax Income -5.03M -5.18M -5.42M -3.90M -2.83M -11.34M -14.33M -12.94M -10.16M -8.20M 3.73M -5.43M -7.33M -7.95M -8.23M -17.66M -20.34M -19.78M -21.23M -16.17M n/a -1.47M -143.00K
Net Income -4.83M -5.15M -5.09M -4.62M -2.95M -11.80M -14.33M 9.27M -10.16M -8.20M 3.73M -5.43M -7.33M -7.95M -8.23M -17.66M -20.34M -19.78M -23.10M -16.53M -7.30M -1.59M -167.00K
Selling & General & Admin 7.58M 8.84M 9.76M 9.45M 13.66M 18.62M 19.92M 17.07M 15.56M 12.41M 11.56M 11.89M 13.20M 11.60M 9.90M 13.86M 13.73M 16.52M 15.93M 12.49M n/a 2.10M 1.33M
Research & Development 1.87M 207.00K 125.00K 555.00K 1.34M 1.52M 1.57M 1.58M 1.81M 1.53M 2.89M 2.22M 1.98M 2.05M 2.00M 6.25M 9.78M 4.51M 2.60M 1.65M n/a 68.00K 6.00K
Other Expenses n/a -631.00K -394.00K -594.00K 240.00K -239.00K -357.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 9.45M 9.05M 9.88M 10.01M 15.00M 20.14M 21.50M 18.64M 17.36M 13.95M 14.45M 14.12M 15.18M 13.65M 11.89M 20.11M 23.51M 21.03M 18.53M 14.15M n/a 2.17M 1.33M
Interest Expense n/a 16.00K 10.00K 12.00K 16.00K 33.00K 40.00K 3.00K 3.00K 3.00K 1.06M 1.11M 931.00K 406.00K 9.00K 437.00K n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses 156.00K 156.00K 86.00K 41.00K 35.00K 157.00K 177.00K 149.00K 175.00K 231.00K 155.00K 91.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 17.44M 17.84M 18.52M 22.08M 25.61M 30.23M 30.85M 25.80M 25.24M 20.51M 19.72M 18.83M 19.21M 17.26M 15.38M 22.70M 26.26M 24.03M 23.43M 17.67M n/a 3.94M 2.15M
Income Tax -196.00K -33.00K -332.00K 713.00K 121.00K 458.00K -807.00K -4.27M -241.00K -250.00K 774.00K 839.00K 862.00K 443.00K -217.00K 349.00K -2.09M 299.00K 2.25M 218.00K 8.04M 123.00K 24.00K
Shares Outstanding (Basic) 454.50K 169.70K 132.65K 99.80K 73.85K 46.20K 25.15K 23.47K 18.27K 10.73K 7.65K 5.53K 4.35K 4.19K 3.65K 2.57K 2.02K 864.75 658.70 621.25 620.75 607.45 602.35
Shares Outstanding (Diluted) 454.50K 169.70K 132.65K 99.80K 73.85K 46.20K 25.17K 23.72K 18.27K 10.73K 7.66K 5.53K 4.35K 4.19K 3.65K 2.57K 2.02K 864.75 658.70 621.25 620.75 607.45 602.35
EPS (Basic) -10.64 -30.4 -38.4 -46.2 -39.8 -255.4 -569.8 390.60 -556.2 -764.4 486.00 -982 -1.69K -1.90K -2.26K -6.86K -10.06K -22.88K -35.07K -26.61K -11.76K -2.63K -277.2
EPS (Diluted) -10.64 -30.4 -38.4 -46.2 -39.8 -255.4 -569.4 390.60 -556.2 -764.4 486.00 -981.8 -1.69K -1.90K -2.26K -6.86K -10.06K -22.88K -35.07K -26.61K -11.76K -2.63K -277.2
EBITDA -4.53M -4.45M -5.70M -3.22M -3.22M -10.85M -13.80M -12.69M -14.48M -7.95M -5.77M -4.06M -6.07M -7.15M -7.79M -16.45M -22.43M -18.81M -20.20M -15.88M 902.00K -1.46M -151.00K
Depreciation & Amortization 176.00K 298.00K 409.00K 227.00K 312.00K 453.00K 490.00K 248.00K 244.00K 253.00K 284.00K 268.00K 326.00K 395.00K 433.00K 768.00K 740.00K 672.00K 651.00K 434.00K 160.00K 4.00K -4.00K